Fu-Shan Xue | Clinical Medicine | Outstanding Scientist Award

Prof. Fu-Shan Xue | Clinical Medicine | Outstanding Scientist Award

Fuzhou University Affiliated Provincial Hospital | China

Author Profile

Scopus

Orcid ID

🎓 THE REMARKABLE JOURNEY OF FU-SHAN XUE: A TRAILBLAZER IN ANESTHESIOLOGY

🎓 EARLY ACADEMIC PURSUITS

Fu-Shan Xue’s academic journey laid a strong foundation for his outstanding future career. His deep passion for medical sciences, particularly anesthesiology and surgery, led him to pursue rigorous academic training, culminating in his appointment as a Doctoral Supervisor. His dedication during his formative academic years built the groundwork for his later roles as a Chief Physician and Distinguished Professor at Beijing Anzhen Hospital, Capital Medical University.

🏥 PROFESSIONAL ENDEAVORS

Dr. Xue’s professional career is marked by exceptional achievements and prestigious appointments. Serving as the Chief Physician and Professor at the Anesthesiology and Surgery Center of Beijing Anzhen Hospital, he became one of the leading figures in the field. Beyond his hospital responsibilities, he has been recognized as:

  • National Candidate of the "New Century Millions of Talents Project",

  • Expert with Special Allowance of the State Council,

  • Young and Middle-Aged Expert with Outstanding National Contributions,

  • Leading Talent of the National "Ten-Thousand Talents Program".

These distinctions reflect his national and international stature as a pioneering anesthesiologist.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON CLINICAL MEDICINE

Dr. Xue has significantly advanced the field of anesthesiology through his extensive research and innovation. His focus spans various critical areas, including:

  • Innovative techniques in anesthesia and perioperative medicine,

  • Enhancing patient safety during surgical procedures,

  • Developing new surgical and anesthetic methodologies.

His contributions have led to real-world advancements in clinical practices, making surgeries safer and improving patient outcomes.

🌍 IMPACT AND INFLUENCE

The impact of Dr. Xue’s work extends far beyond the walls of his institution:

  • Published more than 1,180 academic papers, including over 830 as the first and corresponding author in SCI-indexed journals,

  • Edited and translated 15 professional books that serve as key references in the field,

  • Achieved 86 national patents (including 11 invention patents) and 10 foreign patents,

  • Honored with 8 prestigious awards at the provincial and ministerial levels.

Dr. Xue’s influence resonates through medical education, research innovation, and clinical excellence in China and globally.

📈 ACADEMIC CITATIONS

Given his prolific research output, Dr. Xue’s work has been widely cited across national and international medical communities. His extensive citation record demonstrates the foundational importance of his research in advancing anesthesiology and surgery disciplines. He stands as a major reference point for upcoming anesthesiologists and researchers worldwide.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

Fu-Shan Xue’s legacy is already deeply entrenched in the history of anesthesiology:

  • A pioneer in bridging clinical practice and innovative research,

  • A mentor to new generations of physicians and researchers,

  • An architect of safer and more effective anesthesia practices.

Looking ahead, Dr. Xue continues to drive cutting-edge innovations, pursue international collaborations, and mentor young talents. His future contributions are expected to further revolutionize perioperative medicine, enhance global surgical standards, and inspire countless young professionals to follow in his footsteps.

🏅 AWARDS AND HONORS

  • China Distinguished Research Award of Anaesthesia

  • China Distinguishable Anaesthetist Award

  • Wu Yang Medical Medicine Award

  • Nie Jiedong Medical Award

  • Health Defender of Healthy China

  • Top 10 Innovative Medical Experts

These accolades underscore his unparalleled contributions to the advancement of medical science and patient care.

📑NOTABLE PUBLICATIONS

"The UCP2/PINK1/LC3b-mediated mitophagy is involved in the protection of NRG1 against myocardial ischemia/reperfusion injury

  • Authors: X., Li, Xintao , X., Li, Xinyue , T., Tian, Tian , M., Jin, Mu , F., Xue, Fushan
  • Journal: Redox Biology
  • Year: 2025

"Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy

  • Authors: Y., Gao, Ying , L., Li, Lu , F., Zhao, Fang , M., Jin, Mu , F., Xue, Fushan
  • Journal: Drug Design, Development and Therapy
  • Year: 2025

"Subglottic airway injury during fiberscope-monitored intubation with a supraglottic airway device: A randomized controlled comparison of three tracheal tubes

  • Authors: K., Su, Kai , S., Xu, Shangjun , H., Wang, Haixia , F., Xue, Fushan , M., Tian
  • Journal: Ming Chinese Medical Journal
  • Year: 2025

Dina Jiesisibieke | Reproductive Health | Best Researcher Award

Ms. Dina Jiesisibieke | Reproductive Health | Best Researcher Award

Peking University Third Hospital | China

Author Profile

Scopus

Google Scholar

📌 DINA JIESISIBIEKE, M.D. CANDIDATE

🏥 CLINICAL MEDICINE AT PEKING UNIVERSITY THIRD HOSPITAL Peking University

🎓 EARLY ACADEMIC PURSUITS

Dina Jiesisibieke embarked on her medical journey at Peking University Third Hospital, where she has been pursuing a Doctor of Medicine (M.D.) degree since 2019. With an impressive GPA of 3.7/4.0, she has consistently demonstrated academic excellence and dedication to the field of clinical medicine. Her early academic years were marked by outstanding achievements, securing multiple scholarships and honors for her exceptional performance.

🏆 PROFESSIONAL ENDEAVORS

Beyond her academic pursuits, Dina has actively engaged in research and international exchange programs. In 2023, she participated in an exchange program at Mahidol University, where she gained hands-on experience in plastic surgery. This international exposure has broadened her clinical expertise and provided her with a global perspective on medical practices.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON REPRODUCTIVE HEALTH

Dina's research primarily focuses on reproductive medicine, specifically evaluating reproductive outcomes of conventional in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Her work was recognized at the prestigious American Society for Reproductive Medicine (ASRM) conference in 2023, where she submitted a research abstract detailing her cohort study on reproductive outcomes.

🌍 IMPACT AND INFLUENCE

Dina's contributions extend beyond academic excellence, as she actively participates in scholarly discourse and medical research. Her involvement in clinical studies and international exchange programs positions her as an emerging leader in the medical field. Through her dedication to medical research and clinical training, she continues to inspire and set a benchmark for aspiring medical professionals.

📚 ACADEMIC CITATIONS

Her research has been recognized at a high level, with a conference abstract submitted to the American Society for Reproductive Medicine. This recognition highlights her growing influence in reproductive medicine and her commitment to contributing valuable insights to the medical community.

🏅 SCHOLARSHIPS AND AWARDS

Dina has been the recipient of numerous prestigious scholarships and awards, recognizing her academic excellence and dedication:

  • Merit Student of Peking University
  • Peking University Southwest Associated University Guan Yanhui Medical Education Scholarship (2019-2021)
  • Model Student of Academic Records of Peking University (2020-2024)
  • Peking University Weicai Pharmaceutical Scholarship (2021-2022)

🌟 LEGACY AND FUTURE CONTRIBUTIONS

As an aspiring physician, Dina Jiesisibieke is committed to advancing the field of clinical medicine and reproductive health. Her contributions to research, combined with her strong academic foundation and clinical experience, set the stage for a promising career in medicine. With continued dedication, she is poised to make a lasting impact in the field of reproductive medicine and beyond.

📑NOTABLE PUBLICATIONS 

"Prevalence of eye and adnexal disorders among elderly inmates in Taiwan prisons

  • Authors: C., Tsai, Chingyao , Z.L., Jiesisibieke, Zhu Liduzi , P., Tao, Ping , C., Chien, Chingwen , T., Tung, Taohsin
  • Journal: BMC Public Health
  • Year: 2024

Wei Wu | DNA Methylation and Male Reproductive Health | Best Researcher Award

Prof Dr. Wei Wu | DNA Methylation and Male Reproductive Health | Best Researcher Award

Nanjing Medical University | China

AUTHOR PROFILE

Scopus

orcid ID

EARLY ACADEMIC PURSUITS

Wei Wu began his academic journey at Nanjing Medical University, where he earned a Bachelor of Science in Preventive Medicine in 2007. He continued his studies at the same institution, obtaining a Ph.D. in Toxicology in 2012. His doctoral research was conducted in the Department of Toxicology, focusing on toxicological mechanisms and their implications for public health. Following his Ph.D., Wu completed a postdoctoral fellowship in Reproductive and Developmental Toxicology at the State Key Laboratory of Reproductive Medicine, also at Nanjing Medical University. In 2017-2018, he broadened his research horizons as a guest researcher at the National Institute of Environmental Health Sciences in the United States, specializing in Epidemiology.

PROFESSIONAL ENDEAVORS

Wei Wu's professional career is anchored at Nanjing Medical University, where he has ascended from a research assistant to a professor. His roles include:

  • 2022-present: Professor, Department of Toxicology, School of Public Health
  • 2022-present: Assistant Dean, School of Public Health
  • 2022-present: Secretary General, Jiangsu Society of Toxicology
  • 2021-present: Associate Department Chair, Department of Scientific Research Sharing Platform (Core Facility)
  • 2018-present: Associate Department Chair, Department of Toxicology
  • 2016-2022: Associate Professor, Department of Toxicology
  • 2012-2016: Lecturer, Department of Toxicology
  • 2010-2012: Research Assistant, School of Public Health

CONTRIBUTIONS AND RESEARCH FOCUS ON DNA METHYLATION AND MALE REPRODUCTIVE HEALTH

Wei Wu has made significant contributions to the field of toxicology, particularly in reproductive and developmental toxicology. His research has focused on the toxicological effects of environmental and chemical exposures on reproductive health. His work also delves into the molecular mechanisms underlying these toxicological impacts, aiming to develop preventive strategies and therapeutic interventions.

IMPACT AND INFLUENCE

Wei Wu has received numerous honors and awards that reflect his impact and influence in the field of toxicology. Notable accolades include:

  • 2023: "Good Youth Around Us" by the Communist Youth League Jiangsu Provincial Committee
  • 2022: Friendship Teaching Award of Nanjing Medical University
  • 2020: Ministry of Education Fok Ying Tung Young Teachers' Award
  • 2019: Clarivate Publons Peer Review Awards (top 1% reviewers in Crossfield and Clinical Medicine)
  • 2018: Publons Peer Review Awards (top 1% reviewers in Clinical Medicine)
  • 2017: Multiple awards for excellent papers and teaching achievements

ACADEMIC CITATIONS

Wei Wu holds various editorial positions, contributing to the dissemination of scientific knowledge in toxicology and related fields. He serves on the editorial boards of several prestigious journals, including:

  • Scientific Reports
  • SM Journal of Environmental Toxicology
  • Global Journal of Genitourinary Cancer
  • Austin Journal of Reproductive Medicine & Infertility
  • Journal of Clinical Obstetrics, Gynecology & Infertility
  • Medicine
  • Frontiers in Endocrinology
  • Frontiers in Physiology

As an editor-in-chief, he leads the International Journal of Sexual Health and Reproductive Health Care and the Research International Journal of Endocrinology and Diabetes.

LEGACY AND FUTURE CONTRIBUTIONS

Wei Wu’s ongoing research and professional activities suggest a lasting legacy in the field of toxicology. His leadership roles within professional societies, such as the Jiangsu Society of Toxicology and the Jiangsu Provincial Preventive Medical Association, underline his influence in shaping future research directions and policies. His dedication to teaching and mentoring the next generation of toxicologists ensures that his impact will continue to resonate in the academic and scientific communities.

NOTABLE PUBLICATIONS

Cohort Profile: The Jiangsu Birth Cohort 2023(3)

Effect of prenatal perfluoroheptanoic acid exposure on spermatogenesis in offspring mice 2023(4)

Adverse effect of assisted reproductive technology-related hyperoestrogensim on the secretion and absorption of uterine fluid in superovulating mice during the peri-implantation period 2023(2)

Association between prenatal perfluorinated compounds exposure and risk of pregnancy complications: A meta-analysis 2024

Effect of prenatal exposure to phthalates on birth weight of offspring: A meta-analysis 2024